The impact of treatment with hylan G-F 20 on progression to total hip arthroplasty in patients with symptomatic hip OA: a retrospective study

References

• Andrzejewski T, Gołda W, Gruszka J, et al. Assessment of Synvisc treatment in osteoarthritis. Ortop Traumatol Rehabil 2003;5:379-90
   PubMedGoogle Scholar
• Castro RR, Feitosa JP, da Cunha PL, et al. Analgesic activity of a polysaccharide in experimental osteoarthritis in rats. Clin Rheumatol 2007;26:1312-19; erratum in: Clin Rheumatol 2007;26:1398
   PubMed Web of Science ®Google Scholar
• Modawal A, Ferrer M, Choi HK, et al. Hyaluronic acid injections relieve knee pain. J Fam Pract 2005;54:758-67
   PubMed Web of Science ®Google Scholar
• Wobig M, Dickhut A, Maier R, et al. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 1998;20:410-23
   PubMed Web of Science ®Google Scholar
• Chevalier X, Jerosch J, Goupille P, et al. Single, intra-articular treatment with 6 mL of hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: A randomised, multi-centre, double-blind, placebo-controlled trial. Ann Rheum Dis 2010 Jan;69:113-9
   Google Scholar
• Raman R, Dutta A, Day N, et al. Efficacy of hylan G-F 20 and sodium hyaluronate in the treatment of osteoarthritis of the knee – a prospective randomized clinical trial. Knee 2008;15:318-24
   PubMed Web of Science ®Google Scholar
• Brzusek D, Petron D. Treating knee osteoarthritis with intra-articular hyaluronans. Curr Med Res Opin 2008;24:3307-22
   PubMed Web of Science ®Google Scholar
• Espallargues M, Pons JM. Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis: a systematic review. Int J Technol Assess Health Care 2003;19:41-56
   PubMed Web of Science ®Google Scholar
• Qvistgaard E, Kristoffersen H, Terslev L, et al. Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthritis Cartilage 2001;9:512-17
   PubMed Web of Science ®Google Scholar
• Migliore A, Martin LS, Alimonti A, et al. Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 2003;11:305-6
   PubMed Web of Science ®Google Scholar
• Migliore A, Tormenta S, Martin LS, et al. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol 2005;24:285-9
   PubMed Web of Science ®Google Scholar
• Migliore A, Tormenta S, Martin Martin LS, et al. The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clin Rheumatol 2006;25:389-93
   PubMed Web of Science ®Google Scholar
• Migliore A, Tormenta S, Massafra U, et al. Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice. Curr Med Res Opin 2008;24:1309-16
   PubMed Web of Science ®Google Scholar
• Witteveen AG, Giannini S, Guido G, et al. A prospective multi-centre, open study of the safety and efficacy of hylan G-F 20 (Synvisc) in patients with symptomatic ankle (talo-crural) osteoarthritis. Foot Ankle Surg 2008;14:145-52
   PubMedGoogle Scholar
• Noel E, Hardy P, Hagena FW, et al. Prospective study of the safety and efficacy of hylan G-F 20 in symptomatic shoulder osteoarthritis. Joint Bone Spine 2009;76:670-3
   PubMed Web of Science ®Google Scholar
• Roddy E, Doherty M. Guidelines for management of osteoarthritis published by the American College of Rheumatology and the European League Against Rheumatism: why are they so different? Rheum Dis Clin North Am 2003;29:717-31
   PubMed Web of Science ®Google Scholar
• Fioravanti A, Cantarini L, Chellini F, et al. Effect of hyaluronic acid (MW 500-730 kDa) on proteoglycan and nitric oxide production in human osteoarthritic chondrocyte cultures exposed to hydrostatic pressure. Osteoarthritis Cartilage 2005;13:688-96; erratum in: Osteoarthritis Cartilage 2006;14:504-5
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005;64:669-81
   PubMed Web of Science ®Google Scholar
• Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62
   PubMed Web of Science ®Google Scholar
• Gupta S, Hawker GA, Laporte A, et al. The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatology (Oxford) 2005;44:1531-7
   PubMed Web of Science ®Google Scholar
• Loza E, Lopez-Gomez JM, Abasolo L, et al. Economic burden of knee and hip osteoarthritis in Spain. Arthritis Rheum 2009;61:158-65
   PubMed Web of Science ®Google Scholar
• Altman R, Alarcón G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991;34:505-14
   PubMed Web of Science ®Google Scholar
• Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502
   PubMed Web of Science ®Google Scholar
• Lequesne MG. The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 1997;24:779-81
   PubMed Web of Science ®Google Scholar
• van den Bekerom MP, Rys B, Mulier M. Viscosupplementation in the hip: evaluation of hyaluronic acid formulations. Arch Orthop Trauma Surg 2008;128:275-80
   PubMed Web of Science ®Google Scholar
• Waddell DD, Bricker DC. Total knee replacement delayed with Hylan G-F 20 use in patients with grade IV osteoarthritis. J Manag Care Pharm 2007;13:113-21
   PubMed Web of Science ®Google Scholar
• Stürmer T, Brenner H, Brenner RE, et al. Non-insulin dependent diabetes mellitus (NIDDM) and patterns of osteoarthritis. The Ulm osteoarthritis study. Scand J Rheumatol 2001;30:169-71
   PubMed Web of Science ®Google Scholar
• Burner TW, Rosenthal AK. Diabetes and rheumatic diseases. Curr Opin Rheumatol 2009;21:50-4
   PubMed Web of Science ®Google Scholar
• Lussier A, Cividino AA, McFarlane CA, et al. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 1996;23:1579-85
   PubMed Web of Science ®Google Scholar
• Migliore A, Tormenta S, Iannessi F, et al. [Correlation between radiologic and ultrasonographic patterns and clinical manifestations in symptomatic hip osteoarthritis] Reumatismo. 2007;59:57-65
   Google Scholar
• Zhang W, Robertson J, Jones AC, et al. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 2008;67:1716-23
   PubMed Web of Science ®Google Scholar